Skip to main content
SpringerLink
Log in

Prolonged sedation of lorazepam due to absent UGT2B4/2B7 glucuronidation

  • Letter to the Editor
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  • Chung JY, Cho JY, Yu KS, Kim JR, Lim KS, Sohn DR, Shin SG, Jang IJ (2008) Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects. Clin Pharmacol Ther 83:595–600

    Article  CAS  PubMed  Google Scholar 

  • Halama B, Hohmann N, Burhenne J, Weiss J, Mikus G, Haefeli WE (2013) A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions. Clin Pharmacol Ther 93:564–571

    Article  CAS  PubMed  Google Scholar 

  • Katzenmaier S, Markert C, Riedel KD, Burhenne J, Haefeli WE, Mikus G (2011) Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using a limited sampling strategy. Clin Pharmacol Ther 90:666–673

    Article  CAS  PubMed  Google Scholar 

  • Miyakawa H, Kikazawa E, Abe K, Kikuchi K, Fujikawa H, Matsushita M, Kawaguchi N, Morizane T, Ohya K, Kako M (1999) Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases. Autoimmunity 30:107–114

    Article  CAS  PubMed  Google Scholar 

  • Seo KA, Bae SK, Choi YK, Choi CS, Liu KH, Shin JG (2010) Metabolism of 1’- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyl-transferases 1A4, 2B4, and 2B7. Drug Metab Disp 38:2007–2013

    Article  CAS  Google Scholar 

  • Zhu B, Bush D, Doss GA, Vincent S, Franklin RB, Xu S (2008) Characterization of 1’-hydroxymidazolam glucuronidation in human liver microsomes. Drug Metab Disp 36:331–338

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Monika Mauer for technical support during analytical procedures.

Conflict of interest

No conflicts of interest are declared by any of the authors.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany

    Nelly Siller, Johanna Weiss & Gerd Mikus

  2. Department of Internal Medicine V: Haematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany

    Gerlinde Egerer

Authors
  1. Nelly Siller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerlinde Egerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johanna Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gerd Mikus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerd Mikus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Siller, N., Egerer, G., Weiss, J. et al. Prolonged sedation of lorazepam due to absent UGT2B4/2B7 glucuronidation. Arch Toxicol 88, 179–180 (2014). https://doi.org/10.1007/s00204-013-1173-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-013-1173-7

Keywords

Search

Navigation